By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BioMarker Strategies said today that it has won a Phase II contract valued at up to $2.3 million from the National Cancer Institute to develop its live tumor cell testing system.
Registering provides access to this and other free content.
Already have an account?Login Now.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.
Some science companies will be taking part in next month's March for Science, Fortune reports.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.